Ovarian Cancer
5 videos · last 6 months shuffled daily, then older videos newest first
▶
55:03 Early Phase Trials in Ovarian and Gynecologic Cancers
Debra Richardson, MD, Chief of Gynecologic Oncology at the University of Oklahoma, explains how first-in-human Phase I studies work, which therapies are in early development and how precision medicine is shaping ovarian cancer care, for Ovarcome.
▶
29:49 Precision Medicine and Clinical Trials in Ovarian Cancer
Joyce Liu, MD, Director of Clinical Research in Gynecologic Oncology at Dana-Farber Cancer Institute, discusses precision medicine, targeted therapies and clinical trials in ovarian cancer, for Ovarcome.
▶
37:27 Genelux's Olvi-Vec in Platinum-Resistant Ovarian Cancer
Thomas Zindrick of Genelux Corporation discusses Olvi-Vec, an oncolytic virus therapy being developed to resensitise platinum-resistant ovarian cancer to chemotherapy, for Power to the Patients.
▶
1:00:54 How Cancer Research Becomes Treatment: Trials Explained
An OCRA panel including Roisin O'Cearbhaill, MD, and Alessia Baccarini, PhD, explains how cancer drugs move from laboratory to approval, covering trial phases, consent, safety oversight and eligibility, with an ovarian cancer survivor on joining a trial.
▶
2:44 Ovarian Cancer Clinical Trial for PARP Inhibitor
PARP Inhibitor clinical trials for Advanced Ovarian Cancer show "more clinical benefit" as shown in this video featuring Dr. Theresa Werner, a physician from the Huntsman Cancer Institute, and a patient.